text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 58207-19-5 | Product Number: C2256

Clindamycin Hydrochloride Monohydrate


Purity: >98.0%(T)(HPLC)
Synonyms:
Product Documents:
5G
$124.00
15   ≥100  Contact Us
25G
$319.00
1   39   Contact Us

* Please contact our distributors or TCI to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.


Product Number C2256
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__1__8H__3__3ClN__2O__5S·HCl·H__2O = 479.46 
Physical State (20 deg.C) Solid
Storage Temperature Room Temperature (Recommended in a cool and dark place, <15°C)
CAS RN 58207-19-5
Related CAS RN 21462-39-5&18323-44-9
Reaxys Registry Number 4070786
PubChem Substance ID 87560446
SDBS (AIST Spectral DB) 52371
Merck Index (14) 2356
MDL Number

MFCD06411091

Specifications
Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 98.0 %
Specific rotation +140 to +147 deg(C=2, H2O)(calcd.on anh.substance)
Water 3.0 to 6.0 %
NMR confirm to structure
Properties (reference)
Melting Point 143 °C
Specific Rotation 143° (C=2,H2O)
GHS
Related Laws:
RTECS# GF2275000
Transport Information:
H.S.code* 2941.90-000
*This code is applied to the products when TCI exports from Japan and not for import in your country.
Application
Clindamycin Hydrochloride: A Semisynthetic Lincosamide Antibiotic with Strong Activity against Anaerobic Bacteria

Clindamycin (7-chloro-lincomycin) hydrochloride is a semisynthetic lincosamide antibiotic derivative of lincomycin [L0166] to replace the 7-hydroxy group with a chlorine atom with inversion of chirality. Clindamycin is usually more active than lincomycin, in particular against anaerobic bacteria. It has broad activity against anaerobic Gram-positive bacteria and anaerobic Gram-negative bacteria with a few exceptions, but less activity against most aerobic Gram-negative bacteria. Clindamycin is also effective in treating Plasmodium falciparum malaria. Clindamycin interacts with the 50s subunit of bacterial ribosomes, and then it inhibits bacterial growth by inhibiting protein synthesis. Bacterial resistance to clindamycin and lincomycin may be caused by methylation of bacterial 23S ribosomal RNA. Clindamycin phosphate [C2257] is a prodrug of clindamycin, and is designed as a highly water soluble form of the poorly water soluble parent compound clindamycin.

References

PubMed Literature


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.